Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics
Longevity Startup Retro Biosciences Raises Funding at $1.8 Billion Valuation
00

Longevity Startup Retro Biosciences Raises Funding at $1.8 Billion Valuation

May 22, 2026

Retro Biosciences raised funding at a $1.8 billion valuation, announced May 22, 2026. The longevity startup, backed by OpenAI CEO Sam Altman, aims to add 10 healthy years to the human lifespan using gene and cell replacement therapies. Retro is running its first clinical trial testing an Alzheimer's pill designed to clear protein aggregates, with data expected around August 2026.

Retro Biosciences funding round

  • ▪Retro Biosciences raised funding at a $1.8 billion valuation, announced on May 22, 2026
  • ▪Retro Biosciences is backed by OpenAI CEO Sam Altman

Longevity research mission

  • ▪Retro Biosciences is using in vivo gene therapies to spur younger, healthier cells into aging tissues
  • ▪Retro Biosciences has a mission to add 10 healthy years to the human lifespan

Alzheimer's clinical trial

  • ▪Retro Biosciences anticipates releasing data from the Alzheimer's trial around August 2026
  • ▪Retro Biosciences is running its first clinical trial testing a pill designed to enhance the body's ability to clear out protein aggregates in patients with Alzheimer's disease
  • ▪Researchers in the Retro Biosciences Alzheimer's trial have not seen any dose-limiting toxicities
  • ▪Retro Biosciences CEO Joe Betts-LaCroix stated on May 20, 2026 at STAT's Breakthrough Summit West that the Alzheimer's trial is going "super good"

1 source

Statnews
STAT+: Longevity startup Retro Biosciences says latest fundraising values it at $1.8 billion
View source article

Featured stories

View more in Longevity biotech founders

Trump administration to designate Nvidia, Amazon, OpenAI as AI 'national champions'

Nov 16, 2026 · 3 sources

Alibaba unveils Qwen4-Max flagship AI model

Nov 16, 2026 · 2 sources

OpenAI board member warns AI 'takeover' of society could be months away

Nov 13, 2026 · 2 sources

OpenAI launches ChatGPT Wallet, letting AI agents make purchases for users

Nov 13, 2026 · 6 sources

Story comments

Loading comments…

Topics

Longevity biotech foundersLongevity & biohackingLongevity & agingLifestyle, Wellness and NutritionSam AltmanOpenAIPharma

Featured stories

View more in Longevity biotech founders

Trump administration to designate Nvidia, Amazon, OpenAI as AI 'national champions'

Nov 16, 2026 · 3 sources

Alibaba unveils Qwen4-Max flagship AI model

Nov 16, 2026 · 2 sources

OpenAI board member warns AI 'takeover' of society could be months away

Nov 13, 2026 · 2 sources

OpenAI launches ChatGPT Wallet, letting AI agents make purchases for users

Nov 13, 2026 · 6 sources